,0
symbol,PULM
price,1.13
beta,1.65289
volAvg,453935
mktCap,38880476
lastDiv,0.0
range,0.72-2.055
changes,0.03
companyName,Pulmatrix Inc
currency,USD
cik,
isin,US74584P2020
cusip,74584P202
exchange,NASDAQ Global Market
exchangeShortName,NASDAQ
industry,Biotechnology
website,http://www.pulmatrix.com/
description,"Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The company is headquartered in Lexington, Massachusetts and currently employs 6 full-time employees. The Companyâ€™s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition, the Company focuses on pulmonary diseases through collaboration with partners, including PUR0200, a generic in clinical development for chronic obstructive pulmonary disease."
ceo,Mr. Teofilo Raad
sector,Healthcare
country,US
fullTimeEmployees,22
phone,17813572333
address,99 Hayden Ave Ste 390
city,Lexington
state,MASSACHUSETTS
zip,02421
dcfDiff,
dcf,2.61075
image,https://financialmodelingprep.com/image-stock/PULM.png
ipoDate,2014-03-21
defaultImage,False
